메뉴 건너뛰기




Volumn 28, Issue 2, 2015, Pages 168-171

Primary maternal cytomegalovirus infections during pregnancy: Association of CMV hyperimmune globulin with gestational age at birth and birth weight

Author keywords

Cytomegalovirus; Immunoglobulin; Pregnancy

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN;

EID: 84920050921     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.907265     Document Type: Article
Times cited : (27)

References (11)
  • 1
    • 74149084419 scopus 로고    scopus 로고
    • Human cytomegalovirus in uterotransmission: Follow-up of 524 maternal seroconversions
    • Bodéus M, Zech F, Hubinont C, et al. Human cytomegalovirus in uterotransmission: follow-up of 524 maternal seroconversions. J Clin Virol 2010;47:201-2.
    • (2010) J Clin Virol , vol.47 , pp. 201-202
    • Bodéus, M.1    Zech, F.2    Hubinont, C.3
  • 2
    • 25444434851 scopus 로고    scopus 로고
    • Passive immunization during pregnancy for congenital cytomegalovirus infection
    • Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-4.
    • (2005) N Engl J Med , vol.353 , pp. 1350-1354
    • Nigro, G.1    Adler, S.P.2    La Torre, R.3    Best, A.M.4
  • 3
    • 84864459300 scopus 로고    scopus 로고
    • Early primary CMV infection in pregnancy: Maternal hyperimmune globulin therapy improves children's outcome at one year
    • Visentin S, Manara R, Milanese L, et al. Early primary CMV infection in pregnancy: maternal hyperimmune globulin therapy improves children's outcome at one year. Clin Infect Dis 2012;55: 497-503.
    • (2012) Clin Infect Dis , vol.55 , pp. 497-503
    • Visentin, S.1    Manara, R.2    Milanese, L.3
  • 4
    • 84555187476 scopus 로고    scopus 로고
    • Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy: A case-control study of the outcome in children
    • Nigro G, Adler SP, Parruti G, et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy: a case-control study of the outcome in children. J Infect Dis 2012;205:215-22.
    • (2012) J Infect Dis , vol.205 , pp. 215-222
    • Nigro, G.1    Adler, S.P.2    Parruti, G.3
  • 5
    • 84920060187 scopus 로고    scopus 로고
    • The Food and Drug Administration(FDA) Center for Biologics Evaluation and Research (CBER) the National Institutes of Health the National Institute of Allergy and Infectious Diseases (NIAID) the Centers for Disease Control and Prevention and the National Vaccine Program Office [last accessed 10 Jan 2012]
    • Revello MG. Role of antibodies and CMI in preventing congenital CMV. The Development and Evaluation of Human Cytomegalovirus Vaccines, Public Workshop, 10 January 2012. The Food and Drug Administration(FDA) Center for Biologics Evaluation and Research (CBER), the National Institutes of Health, the National Institute of Allergy and Infectious Diseases (NIAID), the Centers for Disease Control and Prevention and the National Vaccine Program Office. Available from: http://videocast.nih.gov/pastevents.asp?c=1 [last accessed 10 Jan 2012].
    • Role of Antibodies and CMI in Preventing Congenital CMV. The Development and Evaluation of Human Cytomegalovirus Vaccines Public Workshop 10 January 2012
    • Revello, M.G.1
  • 6
    • 84869389260 scopus 로고    scopus 로고
    • Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: A retrospective analysis
    • Buxmann H, Stackelberg OM, Schlöber L, et al. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 2012;40:439-46.
    • (2012) J Perinat Med , vol.40 , pp. 439-446
    • Buxmann, H.1    Stackelberg, O.M.2    Schlöber, L.3
  • 7
    • 0025273760 scopus 로고
    • Impact of asymptomatic congenital cytomegalovirus infection on size at birth and gesta-tional duration
    • Berge P, Stagno S, Federer W, et al. Impact of asymptomatic congenital cytomegalovirus infection on size at birth and gesta-tional duration. Pediatr Infect Dis J 1990;9:170-5.
    • (1990) Pediatr Infect Dis J , vol.9 , pp. 170-175
    • Berge, P.1    Stagno, S.2    Federer, W.3
  • 8
    • 84903669056 scopus 로고    scopus 로고
    • Cytomegalovirus infection and antibody protection of the developing placenta
    • Pereira L, Petitt M, Tabata T. Cytomegalovirus infection and antibody protection of the developing placenta. Clin Infect Dis 2013;57:S174-7.
    • (2013) Clin Infect Dis , vol.57 , pp. S174-S177
    • Pereira, L.1    Petitt, M.2    Tabata, T.3
  • 9
    • 0030638633 scopus 로고    scopus 로고
    • Clinical uses of intravenous immunoglobulin in pregnancy
    • Clark AL, Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997;176:241-53.
    • (1997) Am J Obstet Gynecol , vol.176 , pp. 241-253
    • Clark, A.L.1    Gall, S.A.2
  • 10
    • 33750319298 scopus 로고    scopus 로고
    • Placental enlargement in women with a primary maternal cytomegalovirus infection is associated with fetal and neonatal disease
    • La Torre R, Nigro G, Mazzocco M, et al. Placental enlargement in women with a primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006;43: 994-1000.
    • (2006) Clin Infect Dis , vol.43 , pp. 994-1000
    • La Torre, R.1    Nigro, G.2    Mazzocco, M.3
  • 11
    • 77956539713 scopus 로고    scopus 로고
    • Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection
    • Maidji E, Nigro G, Tabata T, et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 2010;177:1298-310.
    • (2010) Am J Pathol , vol.177 , pp. 1298-1310
    • Maidji, E.1    Nigro, G.2    Tabata, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.